Patents by Inventor Beth Cindy Levine

Beth Cindy Levine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Beclin, a novel bcl-2 interacting gene near BRCA1 on chromosome 17q21 and methods of use
    Patent number: 5858669
    Abstract: This invention provides for an isolated nucleic acid which encodes a wildtype human Beclin and a mutant human Beclin. This invention also provides a vector containing the isolated nucleic acid which encodes a wildtype human Beclin. This invention also provides for a method of producing a wildtype human Beclin. This invention also provides for a purified, wildtype human Beclin. This invention also provides for a method for determining whether a subject has a predisposition for cancer. This invention also provides a method for determining whether a subject has cancer. This invention also provides for a method for inhibiting cell proliferation in cells unable to regulate themselves. This invention also provides for a method for treating a subject who has cancer. This invention also provides a pharmaceutical composition composed of the wildtype human Beclin. This invention also provides a method for detecting a mutant human Beclin in a subject.
    Type: Grant
    Filed: September 13, 1996
    Date of Patent: January 12, 1999
    Assignee: The Trustees of Columbia University in the City of New York
    Inventor: Beth Cindy Levine
  • Sindbis virus expression system for recombinant antibody production
    Patent number: 5843712
    Abstract: This invention provides a method of expressing a multimeric polypeptide. This invention also provides a method of expressing biologically active recombinant antibodies. This invention also provides an expression cell line capable of producing multimeric polypeptides or biologically active recombinant antibodies. This invention also provides methods of producing biologically active recombinant antibodies or multimeric polypeptides. This invention also provides a transgenic animal comprising the expression cell line capable of producing biologically active recombinant antibodies or multimeric polypeptides. Also, this invention provides a method for preventing infectious diseases associated with arthropods.
    Type: Grant
    Filed: June 6, 1996
    Date of Patent: December 1, 1998
    Assignee: The Trustees of Columbia University in the City of New York
    Inventor: Beth Cindy Levine